Finance

Lists
EYPT:NASDAQ
EyePoint Inc
$13.89
0.00%
(0.00) 1D
$14.32
+3.10% (+0.43)
Pre-market
Closed: Aug 7, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EYPT...
Mkt. cap
1.20B
Avg. vol.
1.74M
Volume
5.41K
52-wk high
$19.11
52-wk low
$9.65
EPS
-$3.74
Beta
1.76
Shares outstanding
86.21M
No. of employees
214
Mkt. cap
1.20B
Avg. vol.
1.74M
Volume
5.41K
52-wk high
$19.11
52-wk low
$9.65
EPS
-$3.74
Beta
1.76
Shares outstanding
86.21M
No. of employees
214
News stories
From sources across the web
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery. pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner. In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Websiteeyepoint.bio
Analyst ratings
Based on 12 analysts giving stock ratings to EYPT in the past 3 months
Strong buy
Buy
12
Hold
0
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for EYPT in the last 3 months.
Highest
Current $13.89
$68.00 (+389.56%)
Average
$40.75 (+193.38%)
Lowest
$20.00 (+43.99%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lisa Walter
RBC Capital
Buy
Reiterated
$37.00
+166.4%
08/06/2026
Yi Chen
H.C. Wainwright
Buy
Reiterated
$27.00
+94.4%
08/06/2026
Tara Bancroft
TD Cowen
Buy
Maintained
$20.00
+44%
08/05/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
$43.00
+209.6%
08/05/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Maintained
$55.00
+296%
08/05/2026
Yigal Nochomovitz
Citi
Buy
Maintained
$35.00
+152%
08/05/2026
Graig Suvannavejh
Mizuho Securities
Buy
Reiterated
$39.00
+180.8%
07/29/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
$30.00
+116%
07/22/2026
Annabel Samimy
Stifel Nicolaus
Buy
Initiated
$40.00
+188%
07/16/2026
David Siffringer
Cantor Fitzgerald
Buy
Initiated
$47.00
+238.4%
07/08/2026
Daniil Gataulin
Chardan Capital
Buy
Maintained
$65.00
+368%
07/01/2026
Andreas Argyrides
Chardan Capital
Buy
Maintained
$65.00
+368%
07/01/2026
Unknown Analyst
Jefferies
Buy
Maintained
$30.00
+116%
06/25/2026
Yatin Suneja
Guggenheim
Buy
Reiterated
$68.00
+389.6%
06/24/2026
Unknown Analyst
Guggenheim
Buy
Reiterated
$68.00
+389.6%
06/24/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
966.00K
620.00K
696.00K
507.00K
Cost of goods sold
47.46M
58.58M
71.67M
82.55M
Cost of revenue
47.46M
58.58M
71.67M
82.55M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.53M
12.39M
16.26M
15.34M
Operating expense
15.53M
12.39M
16.26M
15.34M
Total operating expenses
62.99M
70.96M
87.92M
97.89M
Operating income
-62.02M
-70.34M
-87.23M
-97.38M
Other non operating income
-
-
-
-
EBT including unusual items
-59.73M
-67.42M
-84.88M
-94.47M
EBT excluding unusual items
-59.73M
-67.42M
-84.88M
-94.47M
Income tax expense
-
186.00K
-50.00K
-
Effective tax rate
-
-0.28%
0.06%
-
Other operating expenses
-
-
-
-
Net income
-59.73M
-67.61M
-84.83M
-94.47M
Net profit margin
-6,183.44%
-10,904.68%
-12,188.51%
-18,633.14%
Earnings per share
-0.85
-0.81
-0.99
-1.09
Interest and investment income
2.29M
2.96M
2.34M
2.91M
Interest expense
-
-33.00K
-
-
Net interest expenses
2.29M
2.92M
2.34M
2.91M
Depreciation and amortization charges
-
-
-
-
EBITDA
-61.45M
-69.65M
-86.59M
-96.69M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps